Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy.

Teuta Zoto MustafayevMenekse TurnaYasemin BolukbasiEvrim TezcanliYildiz GuneyFazilet Oner DincbasBeste Melek AtasoyGamze UgurluerHale Basak CaglarBanu AtalarEnis Ozyar

Published in: BMC cancer (2024)

The use of BV caused clinical response rate of 77.5% and a good radiological response in corticosteroid unresponsive patients. The role of BV should be further investigated in prospective studies.

Keyphrases

end stage renal disease
chronic kidney disease
lps induced
ejection fraction
newly diagnosed
early stage
radiation therapy
prognostic factors
peritoneal dialysis
white matter
squamous cell carcinoma
locally advanced
atomic force microscopy
brain injury
subarachnoid hemorrhage
case control
smoking cessation